https://mavengity.com/articles/finance/fed-first-hike-since-2023-was-the-easy-part/ Mavengity en 2026-09-16T21:07:03+02:00 The Fed's First Hike Since 2023 Was the Easy Part https://mavengity.com/articles/healthcare-medical/medtronic-ligasure-hugo-clearance/ Mavengity en 2026-09-16T15:42:13+02:00 Medtronic Filled the Missing Piece in Its Robot Pitch https://mavengity.com/articles/healthcare-medical/trutakna-origin-3-final-analysis-igan/ Mavengity en 2026-09-16T14:33:01+02:00 Trutakna's Confirmatory Trial Delivered the Number the Label Was Missing https://mavengity.com/articles/healthcare-medical/ivonescimab-harmoni-os-wclc-2026/ Mavengity en 2026-09-16T14:32:57+02:00 Ivonescimab's Strongest Proof Is Half a World Away https://mavengity.com/articles/legal/paramount-wbd-settlement-talks-ticking-fee/ Mavengity en 2026-09-16T14:32:53+02:00 The Meter Is Running on the Paramount-Warner Bros. Deal https://mavengity.com/articles/finance/openai-1-2-trillion-valuation-burn-math/ Mavengity en 2026-09-16T14:32:48+02:00 OpenAI's $1.2 Trillion Number Comes With a $17 Billion Footnote https://mavengity.com/articles/finance/canada-productivity-mega-deduction-6-4-metr/ Mavengity en 2026-09-16T14:32:43+02:00 Canada's New Investment Pitch Is a Number: 6.4 Percent https://mavengity.com/articles/finance/clarity-act-cloture-fails-crypto-markets/ Mavengity en 2026-09-16T14:32:39+02:00 The Clarity Act Failed Before the Debate Started https://mavengity.com/articles/legal/mail-ballot-rule-scotus-timing-not-merits/ Mavengity en 2026-09-16T14:32:10+02:00 The Mail-Ballot Fight Was Lost on Timing, Not on the Merits https://mavengity.com/articles/mortgage/mba-new-jersey-disparate-impact-lawsuit/ Mavengity en 2026-09-15T21:41:32+02:00 The Mortgage Industry Sues New Jersey Over the Country's Broadest Lending Rule https://mavengity.com/articles/finance/aldermore-sale-nationwide-investec-bids/ Mavengity en 2026-09-15T21:41:28+02:00 A Challenger Bank Goes Up for Sale, and Its Best Feature Is a Legal Cloud https://mavengity.com/articles/finance/fin-com-stablecoin-last-mile-seed/ Mavengity en 2026-09-15T18:41:33+02:00 The Stablecoin Boom's Next Prize Is the Most Boring Mile https://mavengity.com/articles/healthcare-medical/gsk-chimagen-multiple-myeloma-deal/ Mavengity en 2026-09-15T18:41:28+02:00 GSK Bets Up to $750 Million That a Preclinical Drug Can Fix Blood Cancer Therapy's Hardest Problem https://mavengity.com/articles/healthcare-medical/maat013-chmp-negative-re-examination/ Mavengity en 2026-09-15T13:41:31+02:00 Europe's Regulators Reject a Microbiome Therapy, Not Its Science, but Its Trial Design https://mavengity.com/articles/healthcare-medical/definium-dt120-gad-panorama-phase3/ Mavengity en 2026-09-15T13:41:26+02:00 A Psychedelic Drug Clears Its Third Phase 3 Trial, This Time for Anxiety https://mavengity.com/articles/healthcare-medical/zipalertinib-rezilient3-egfr-exon20/ Mavengity en 2026-09-15T13:41:21+02:00 The Trial Won and the Stock Lost. The Lung Cancer Data Behind Both https://mavengity.com/articles/healthcare-medical/gotistobart-squamous-nsclc-survival-data/ Mavengity en 2026-09-15T13:41:15+02:00 In a Lung Cancer Where Survival Rarely Passes a Year, One Drug Nearly Doubled It https://mavengity.com/articles/healthcare-medical/corbus-crb913-obesity-phase1b/ Mavengity en 2026-09-15T13:41:05+02:00 The Obesity Market Gets a Tolerability Play, and It Is Not a GLP-1 https://mavengity.com/articles/healthcare-medical/canadian-prescription-import-ban-october-22/ Mavengity en 2026-09-15T13:17:09+02:00 The Canadian Pharmacy Option Closes for American Patients on October 22 https://mavengity.com/articles/healthcare-medical/vermont-hospital-price-cuts-uvm/ Mavengity en 2026-09-15T13:17:04+02:00 Vermont Cuts Hospital Prices by Order, and Its Biggest Hospital Takes the Deepest Hit https://mavengity.com/articles/insurance/nara-health-14m-self-insured-ai/ Mavengity en 2026-09-15T13:17:01+02:00 A $14 Million Bet That Employers Can Rebuild Health Plans With AI https://mavengity.com/articles/legal/texasldpc-broadcom-patent-suit-revived/ Mavengity en 2026-09-15T13:16:57+02:00 A Contract Clause Revives a Decade-Old Patent Fight Against Broadcom https://mavengity.com/articles/finance/anz-ceo-ai-job-cuts-risk/ Mavengity en 2026-09-15T13:16:53+02:00 ANZ's CEO Sees AI Outpacing Its Own Creators, and Job Cuts Are on the Table https://mavengity.com/articles/mortgage/euribor-jump-portuguese-mortgages/ Mavengity en 2026-09-15T13:16:49+02:00 Europe's Energy Shock Is Landing on Mortgage Bills https://mavengity.com/articles/legal/georgia-tort-reform-trifurcation-appeals/ Mavengity en 2026-09-15T13:16:45+02:00 Georgia's Tort Reform Hit Its First Stress Test, and the Law Lost a Round https://mavengity.com/articles/insurance/warren-private-equity-life-insurers-naic/ Mavengity en 2026-09-15T13:16:42+02:00 Senate Asks State Regulators to Explain Private Equity's Life Insurance Bet https://mavengity.com/articles/mortgage/fha-vantagescore-fico-10t-2027/ Mavengity en 2026-09-15T13:16:38+02:00 The FHA Will Accept New Credit Scores in 2027, and the Mortgage Math Is Changing https://mavengity.com/articles/healthcare-medical/fda-breakthrough-phage-therapy-staph/ Mavengity en 2026-09-15T13:16:34+02:00 Phage Therapy Moves Toward the Mainstream With an FDA Breakthrough Nod